In the News

Searching for metabolic signs of heart problems


Oncologists have known for more than half a century that anthracyclines, a class of drugs used to treat solid tumors, can cause damage to the heart.

Dr. Vlad Zaha, Assistant Professor of Internal Medicine at UT Southwestern and a member of the Harold C. Simmons Comprehensive Cancer Center, is a cardiologist who specializes in heart problems caused by cancer treatment. He was recently awarded a $2.3 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to study the metabolic changes that occur in the heart with anthracycline treatment.

Dr. de Lemos honored with ROTO Award


Cardiologist Dr. James de Lemos, Professor of Internal Medicine, and pediatrician Dr. Dorothy Sendelbach, Assistant Dean of Undergraduate Medical Education at UT Southwestern, have been recognized with the UT System’s highest educational honor, the Regents’ Outstanding Teaching Awards, for their academic prowess and mentoring talent.

UTSW ranked No. 1 for published research


UT Southwestern Medical Center is the No. 1 academic medical center in the world for publishing high-quality scientific research, according to the Nature Index 2018 Annual Tables released today. UT Southwestern is ranked first among peer institutions that include Columbia University Medical Center, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, and UC San Diego Health.

Hobbs awarded Institut de France Grand Prix


UT Southwestern Medical Center geneticist Dr. Helen Hobbs is the 2018 recipient of the Institut de France Grand Prix Scientifique.

The Lefoulon-Delalande Grand Prize in Science, one of the largest awards for scientific achievement and considered one of the most prestigious prizes in the world in cardiovascular research, was awarded to Dr. Hobbs, an Investigator of the Howard Hughes Medical Institute, for her role in the discovery of a novel way to reduce cholesterol.

MRSA infections less costly, but still deadly


Staph infections, whether MRSA (resistant to methicillin) or susceptible, are important and deadly. Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a new national analysis shows.

“The lower costs for treating drug-resistant infections were a surprise,” said Dr. Trish Perl, Chief of Infectious Diseases and Geographic Medicine and a co-author of the study. “The findings are contrary to previous predictions and studies that suggested the treatment costs for drug-resistant infections would be greater.” 

Financial strain has major impact on patients’ health care decisions


Financial strain is the single most important factor in making health care decisions for low-income individuals, who often forgo care in favor of basic needs like food and rent, researchers in UT Southwestern’s Center for Patient-Centered Outcomes Research (PCOR) found.

“Financial strain is the burden that prevents many low-income patients from being able to take better care of themselves,” said lead author Dr. Oanh Nguyen, Assistant Professor of Internal Medicine and Clinical Sciences at UT Southwestern Medical Center. “This financial strain can cause nonadherence to physician recommendations that appear to reflect a patient’s lack of engagement in care. However, this ‘nonadherence’ is actually the result of rational and difficult trade-offs to cope with financial strain.”

Dr. Gerber commentary on clinical trial exclusions


The growing number of exclusions is shrinking the pool of candidates who can participate in trials and causing delays in drug development. Currently, fewer than 2 percent of adult cancer patients in the United States are treated in clinical trials. And research by Dr. David Gerber shows that patients with a history of cancer are excluded in more than 80 percent of lung cancer trials. 

Dr. Ambarish Pandey selected Texas Health Resources Clinical Scholar


UT Southwestern cardiologist Dr. Ambarish Pandey has been named a Texas Health Resources Clinical Scholar. Funding from this award will bolster his studies developing novel approaches to prevent heart failure and improve heart failure outcomes at a health system level.

The $750,000 career development award over three years supports Dr. Pandey’s research on screening and prevention of heart failure, particularly heart failure with preserved ejection fraction, a difficult to treat form of heart failure.

Dr. Beg leads study to evaluate Wearable fitness monitors usefulness in cancer treatment


Wearable fitness trackers, such as Fitbits, that measure steps taken per day may be a useful tool to evaluate and help treat cancer patients, researchers at UT Southwestern’s Simmons Cancer Center have shown.

“This is the first step in understanding how relevant wearable devices are for cancer patients. My hope is that we can use wearable devices in large cancer clinical trials. That way, we can see what the true effect of different cancer treatments are on patients’ physical activity,” said senior author Dr. Muhammad Beg, Assistant Professor of Internal Medicine, a Dedman Family Scholar in Clinical Care, and a member of the Harold C. Simmons Comprehensive Cancer Center.

Dr. Donald W. Seldin, ‘intellectual father’ of UT Southwestern, dies at 97


Dr. Donald W. Seldin, known as the “intellectual father” of UT Southwestern Medical Center, died Wednesday, April 25. He was 97.

The enduring contributions of Dr. Seldin, Professor and Chairman Emeritus of Internal Medicine, placed him among the most distinguished academic medical educators in the history of internal medicine. Throughout his 67-year career at UT Southwestern, his dedication to educating generations of top medical professionals, as well as his success in transforming a small medical school housed in converted Army barracks into one of the nation’s premier medical centers, are all part of the lasting legacy of this giant of medicine and higher education.

Video: Internal Medicine – The Seldin Years